KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareDx (CDNA) EPS (Weighted Average and Diluted) (2016 - 2026)

CareDx's EPS (Weighted Average and Diluted) history spans 14 years, with the latest figure at $0.05 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 126.32% to $0.05 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.16, a 114.29% decrease, with the full-year FY2025 number at -$0.4, down 143.01% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.05 in Q1 2026 for CareDx, up from -$0.08 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CDNA hit a ceiling of $1.6 in Q4 2024 and a floor of -$2.2 in Q4 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.26 across 5 years, with a median of -$0.32 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 3600.0% in 2022 and later skyrocketed 172.73% in 2024.
  • Tracing CDNA's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.35 in 2022, then tumbled by 528.57% to -$2.2 in 2023, then skyrocketed by 172.73% to $1.6 in 2024, then plummeted by 105.0% to -$0.08 in 2025, then surged by 162.5% to $0.05 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CDNA at $0.05 in Q1 2026, -$0.08 in Q4 2025, and $0.03 in Q3 2025.